High blood pressure has long been medicine's quiet adversary — present in over a billion lives, yet often invisible until the damage is done. On World Hypertension Day, Recor Medical draws attention to the stubborn third of patients for whom pills and lifestyle changes are not enough, offering a device-based therapy that quiets the overactive nerves driving their condition. The Paradise ultrasound renal denervation system, FDA-approved since late 2023, represents not a replacement for existing care but an expansion of what medicine can offer those left behind by it. Whether it will endure as a
PR Newswire UK
· May 15, 2026
· health
· 3 min read
High
Sourcing: Characterized
Recor Medical Promotes Ultrasound Therapy for Treatment-Resistant Hypertension
Hypertension affects over 1 billion people globally and remains a leading cause of heart attack, stroke, and kidney disease when uncontrolled.
◉
Health & Medicine
8412 related articles
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% match
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% match
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% match
Related Coverage
BBC News · Aug 25
School asbestos exposure linked to woman's death at 46, family claims
A woman died from mesothelioma at 46, likely exposed to asbestos at her Cardiff school decades earlier. Her family is su…
Future of Personal Health - · Aug 25 NGS Technology Transforms Uncertain Infections Into Actionable DiagnosesHybrid-capture NGS technology helps clinicians identify pathogens in diagnostically challenging cases by simultaneously …
The Guardian · Aug 25 Shark attack survivor Leah Stewart recalls 'monster' in first interview since losing armLeah Stewart, who lost her arm in a June shark attack at Coogee Beach, recalls the traumatic encounter in her first inte…
Education News Canada · Aug 25 Systemic racism, restrictive policies block Black Canadians from blood donationBlack Canadians face systemic barriers to blood donation despite critical need for ethnicity-matched blood for sickle ce…
Bias & Framing
No detailed analysis data available for this lens. Try re-running lenses from the admin panel.
Geopolitical Impact
🌎
Medical device company promotes ultrasound therapy for hypertension; no geopolitical implications detected.
Escalation Risk
low
Confidence
HIGH
Economic Lens
📈
Recor Medical promotes ultrasound renal denervation for treatment-resistant hypertension affecting ~1.3B people globally, targeting the one-third of patients uncontrolled by medication, signaling growth in specialized medical device markets.
Market Signal
bullish
Confidence
MED
Medical devices and diagnostics
Pharmaceutical/healthcare services
Cardiovascular treatment
Healthcare technology
Hospital and clinical services
Patients with resistant hypertension gain access to innovative minimally-invasive treatment options, potentially reducing long-term healthcare costs from cardiovascular complications (heart attacks, strokes, kidney disease) and improving quality of life, though device costs may initially be high.
Regulatory bodies (FDA, EMA) may accelerate approval pathways for innovative hypertension therapies; healthcare systems may need to evaluate reimbursement policies for device-based treatments; public health initiatives may shift toward earlier detection and specialist referral protocols for treatment-resistant cases.